title: Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity later in life.
abstract: Many chemicals in the environment, especially those with estrogenic activity, are able to disrupt the programming of endocrine signaling pathways established during development; these chemicals are referred to as endocrine-disrupting chemicals. Altered programming can result in numerous adverse consequences in estrogen-target tissues, some of which may not be apparent until later in life. For example, a wide variety of structural, functional, and cellular effects have been identified in reproductive tract tissues. In addition to well-documented reproductive changes, obesity and diabetes have joined the list of adverse effects that have been associated with developmental exposure to environmental estrogens and other endocrine-disrupting chemicals. Obesity is a significant public health problem reaching epidemic proportions worldwide. Experimental animal studies document an association of developmental exposure to environmental estrogens and obesity. For example, a murine model of perinatal exposure to diethylstilbestrol has proven useful in studying mechanisms involved in abnormal programming of differentiating estrogen-target tissues, including reproductive tract tissues and adipocytes. Other environmental estrogens, including the environmental contaminant bisphenol A, have also been linked to reproductive problems and obesity later in life. Epidemiology studies support similar findings in humans, as do studies of cells in culture. Together, these findings suggest new targets for abnormal programming by estrogenic chemicals and provide evidence supporting the scientific concept termed the developmental origins of adult disease. Furthermore, the association of environmental estrogens with obesity and diabetes expands the focus on these diseases from intervention or treatment to include prevention or avoidance of chemical modifiers, especially during critical windows of development.
authors.affiliation: Department of Health and Human Services, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA. newbold1@niehs.nih.gov
authors.forename: Retha R
authors.initials: RR
authors.lastname: Newbold
mesh_terms: D017667:Adipocytes; D000818:Animals; D001559:Benzhydryl Compounds; D004054:Diethylstilbestrol / Q000633:toxicity; D052244:Endocrine Disruptors / Q000633:toxicity*; D004781:Environmental Exposure / Q000009:adverse effects*; D004785:Environmental Pollutants / Q000633:toxicity*; D016021:Epidemiologic Studies; D004967:Estrogens / Q000378:metabolism; D004968:Estrogens, Non-Steroidal / Q000633:toxicity; D005260:Female; D006801:Humans; D023421:Models, Animal; D009765:Obesity / Q000453:epidemiology* / Q000209:etiology; D010636:Phenols / Q000633:toxicity; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D015995:Prevalence; D011634:Public Health; D012098:Reproduction / Q000187:drug effects*; D000098826:Bisphenol A Compounds
chemical_list: D001559:Benzhydryl Compounds; D004054:Diethylstilbestrol; D052244:Endocrine Disruptors; D004785:Environmental Pollutants; D004967:Estrogens; D004968:Estrogens, Non-Steroidal; D010636:Phenols; C006780:bisphenol A; D000098826:Bisphenol A Compounds
references.citation: Int J Epidemiol. 2002 Dec;31(6):1235-9
references.pmid: 12540728
references.citation: Mol Cell Endocrinol. 2009 May 25;304(1-2):49-54
references.pmid: 19433247
references.citation: Diabetes. 2007 May;56(5):1382-6
references.pmid: 17470564
references.citation: Int J Androl. 2008 Apr;31(2):288-93
references.pmid: 17971158
references.citation: Reprod Toxicol. 2001 Jan-Feb;15(1):71-4
references.pmid: 11137380
references.citation: J Biosci. 2005 Feb;30(1):65-74
references.pmid: 15824442
references.citation: Environ Health Perspect. 2009 Oct;117(10):1549-55
references.pmid: 20019905
references.citation: J Am Diet Assoc. 2010 Apr;110(4):656
references.pmid: 20338293
references.citation: Mol Cell Endocrinol. 2009 May 25;304(1-2):84-9
references.pmid: 19433252
references.citation: Mol Carcinog. 2003 Oct;38(2):78-84
references.pmid: 14502647
references.citation: Ann Intern Med. 1995 May 15;122(10):778-88
references.pmid: 7717601
references.citation: Matern Child Nutr. 2005 Jul;1(3):130-41
references.pmid: 16881892
references.citation: Endocrinology. 2006 Jun;147(6 Suppl):S11-7
references.pmid: 16690809
references.citation: JAMA. 2010 Jan 20;303(3):235-41
references.pmid: 20071471
references.citation: Endocrinology. 2008 Dec;149(12):5922-31
references.pmid: 18669593
references.citation: Environ Health Perspect. 2006 Jan;114(1):106-12
references.pmid: 16393666
references.citation: In Vivo. 2005 May-Jun;19(3):487-94
references.pmid: 15875766
references.citation: Epidemiol Rev. 2007;29:1-5
references.pmid: 17569676
references.citation: Birth Defects Res A Clin Mol Teratol. 2005 Jul;73(7):481-4
references.pmid: 15959889
references.citation: J Pediatr Hematol Oncol. 2003 Aug;25(8):635-6
references.pmid: 12902917
references.citation: Br J Pharmacol. 2004 Jan;141(2):209-14
references.pmid: 14707028
references.citation: Birth Defects Res A Clin Mol Teratol. 2005 Jul;73(7):469
references.pmid: 15959884
references.citation: Regul Toxicol Pharmacol. 1999 Oct;30(2 Pt 1):156-66
references.pmid: 10536110
references.citation: Int J Androl. 2008 Apr;31(2):194-200
references.pmid: 17971160
references.citation: Nat Genet. 1998 Nov;20(3):228-30
references.pmid: 9806537
references.citation: Hum Reprod. 2006 Mar;21(3):666-9
references.pmid: 16293648
references.citation: JAMA. 1998 Aug 19;280(7):630-4
references.pmid: 9718055
references.citation: Reprod Toxicol. 2007 Aug-Sep;24(2):131-8
references.pmid: 17768031
references.citation: Basic Clin Pharmacol Toxicol. 2008 Feb;102(2):100-8
references.pmid: 18226062
references.citation: Nat Rev Endocrinol. 2010 Jul;6(7):363-70
references.pmid: 20498677
references.citation: Environ Health Perspect. 2008 Dec;116(12):1642-7
references.pmid: 19079714
references.citation: Toxicol Appl Pharmacol. 2004 Sep 1;199(2):142-50
references.pmid: 15313586
references.citation: Environ Health Perspect. 2001 Jul;109(7):675-80
references.pmid: 11485865
references.citation: Endocr J. 2004 Apr;51(2):165-9
references.pmid: 15118266
references.citation: N Engl J Med. 1971 Apr 15;284(15):878-81
references.pmid: 5549830
references.citation: Nature. 1999 Oct 21;401(6755):763-4
references.pmid: 10548101
references.citation: Environ Health Perspect. 2005 Aug;113(8):969-77
references.pmid: 16079065
references.citation: Endocrinology. 2010 Jun;151(6):2603-12
references.pmid: 20351315
references.citation: Reprod Toxicol. 2002 Mar-Apr;16(2):117-22
references.pmid: 11955942
references.citation: Int J Androl. 2010 Apr;33(2):377-84
references.pmid: 20002218
references.citation: Toxicol Sci. 2003 Dec;76(2):247-9
references.pmid: 14677558
references.citation: Mol Endocrinol. 2006 Sep;20(9):2141-55
references.pmid: 16613991
references.citation: Int J Androl. 2008 Apr;31(2):201-8
references.pmid: 18315718
references.citation: Toxicol Sci. 2005 Apr;84(2):319-27
references.pmid: 15659569
references.citation: Biol Reprod. 1997 Dec;57(6):1338-45
references.pmid: 9408238
references.citation: Reprod Toxicol. 2004 Aug-Sep;18(6):803-11
references.pmid: 15279878
references.citation: JAMA. 2008 Sep 17;300(11):1353-5
references.pmid: 18799451
references.citation: J Altern Complement Med. 2002 Apr;8(2):185-92
references.pmid: 12006126
references.citation: J Lipid Res. 2002 May;43(5):676-84
references.pmid: 11971937